Impact of diabetes mellitus on osteoarthritis: a scoping review on biomarkers

Expert Rev Mol Med. 2024 Apr 12:26:e8. doi: 10.1017/erm.2024.7.

Abstract

Osteoarthritis (OA) commonly affects the knee and hip joints and accounts for 19.3% of disability-adjusted life years and years lived with disability worldwide (Refs , ). Early management is important in order to avoid disability uphold quality of life (Ref. ). However, a lack of awareness of subclinical and early symptomatic stages of OA often hampers early management (Ref. ). Moreover, late diagnosis of OA among those with severe disease, at a stage when OA management becomes more complicated is common (Refs , , , ). Established risk factors for the development and progression of OA include increasing age, female, history of trauma and obesity (Ref. ). Recent studies have also drawn a link between OA and metabolic syndrome, which is characterized by insulin resistance, dyslipidaemia and hypertension (Refs , ).

Keywords: biomarkers; diabetes mellitus; inflammation; metabolism; osteoarthritis.

Publication types

  • Review

MeSH terms

  • Biomarkers / metabolism
  • Diabetes Mellitus* / diagnosis
  • Diabetes Mellitus* / etiology
  • Female
  • Humans
  • Osteoarthritis, Hip* / complications
  • Osteoarthritis, Hip* / diagnosis
  • Osteoarthritis, Knee* / complications
  • Osteoarthritis, Knee* / diagnosis
  • Quality of Life

Substances

  • Biomarkers